🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

18,54 USD

Máx. histórico

178,74

2142 días

Split 1:6 del 12/07/2012

Caída desde máximo

-89,63%

Rango 52 semanas

14,68 – 24,68

Variación hoy

+1,20%

Cierre anterior

18,32

Rango de hoy

18,29 – 18,81

Volumen hoy

1.397.929

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,44%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 1 día
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
18/10/2001 42,30 43,92 42,06 42,84 +0,28% 4,40% 5.483
17/10/2001 43,80 44,16 42,72 42,72 -3,52% 3,29% 3.200
16/10/2001 44,34 44,40 42,66 44,28 +1,10% 3,92% 6.200
15/10/2001 42,90 44,64 42,00 43,80 +0,69% 6,15% 9.050
12/10/2001 44,94 44,94 42,60 43,50 -2,55% 5,21% 5.567
11/10/2001 43,80 46,80 42,66 44,64 +1,92% 9,45% 17.267
10/10/2001 43,08 45,90 42,78 43,80 -3,95% 7,24% 15.117
09/10/2001 44,70 45,60 41,10 45,60 +2,01% 10,07% 21.600
08/10/2001 42,60 45,54 42,36 44,70 +0,81% 7,46% 7.167
05/10/2001 42,78 44,40 42,00 44,34 +2,07% 5,61% 7.683
04/10/2001 43,80 45,90 42,72 43,44 -0,82% 7,26% 11.467
03/10/2001 44,70 45,00 43,26 43,80 -3,18% 3,89% 11.817
02/10/2001 45,00 45,90 43,62 45,24 +0,53% 5,07% 5.883
01/10/2001 45,00 45,00 42,00 45,00 +1,35% 6,67% 6.683
28/09/2001 44,04 45,54 42,06 44,40 +0,82% 7,90% 25.183
27/09/2001 41,46 44,16 40,62 44,04 +2,80% 8,54% 10.467
26/09/2001 48,60 48,60 40,68 42,84 -10,75% 16,30% 30.433
25/09/2001 48,60 51,00 44,52 48,00 -1,23% 13,33% 37.683
24/09/2001 42,36 49,20 41,40 48,60 +15,71% 18,41% 37.350
21/09/2001 37,74 42,00 35,76 42,00 +7,69% 16,53% 57.167
20/09/2001 34,56 39,60 34,56 39,00 +8,33% 14,58% 25.583
19/09/2001 35,40 36,84 34,08 36,00 +2,39% 7,80% 30.767
18/09/2001 38,16 38,40 34,92 35,16 -8,44% 9,12% 23.267
17/09/2001 40,68 42,00 37,50 38,40 -12,93% 11,06% 21.683
10/09/2001 42,48 44,40 42,06 44,10 +3,67% 5,51% 11.867
07/09/2001 42,60 42,60 41,70 42,54 -0,42% 2,11% 9.017
06/09/2001 41,70 42,90 40,50 42,72 -1,25% 5,76% 12.183
05/09/2001 44,16 44,40 38,40 43,26 -2,04% 13,59% 42.367
04/09/2001 45,66 46,80 44,16 44,16 -6,36% 5,78% 6.300
31/08/2001 44,10 47,16 43,50 47,16 +5,93% 8,30% 11.917